According to the Zhitong Finance App, Shanwaishan (688410.SH) announced that the company expects to achieve net profit of 151 million yuan to 167 million yuan in the first three quarters of 2026. Compared with the same period of the previous year (statutory disclosure data), it will increase 46.214,400 yuan to 62.0777 million yuan, an increase of 44.23% to 59.41% over the previous year.

As a leading enterprise of domestic blood purification equipment, the company's product market share continued to increase, and the company's market share continued to increase, driving a steady increase in blood purification equipment sales revenue; during the reporting period, the company's self-produced blood purification consumables sales revenue increased dramatically; as production and sales increased, the fixed cost per unit of self-produced consumables decreased further, gross margin increased, and the company's overall profitability was further strengthened.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.